12:00 AM
Nov 16, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Diamyd diabetes vaccine: Phase III completed enrollment

The company completed enrollment of 320 patients aged 10-20 recently diagnosed with Type I diabetes in a double-blind, placebo-controlled, European Phase III trial evaluating...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >